Carle Illinois College of Medicine, part of Urbana-based University of Illinois, has established a research program combining the science of cancer treatment and regenerative medicine.
The Translational Oncology and Regenerative Medicine Laboratory will be led by Mark Cohen, MD, dean of Carle Illinois College of Medicine, according to a June 15 news release from the University of Illinois Urbana-Champaign.
The laboratory’s self-enclosed, fully sterile clean-room facility will serve as the university’s first Good Manufacturing Practice facility.
The program aims to “address cancer and other chronic diseases by developing cellular therapies to treat the disease and restore long-term function afterward,” the release said.
At the Becker's Perioperative Summit, taking place September 14–15 in Chicago, perioperative leaders and healthcare executives will focus on improving operating room efficiency, enhancing patient safety, optimizing staffing and driving innovation across surgical services. Apply for complimentary registration now.
